Compare TISI & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TISI | BEAT |
|---|---|---|
| Founded | 1973 | 2015 |
| Country | United States | United States |
| Employees | 6800 | 16 |
| Industry | Other Consumer Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.9M | 54.2M |
| IPO Year | 1995 | N/A |
| Metric | TISI | BEAT |
|---|---|---|
| Price | $14.53 | $1.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 3.5K | ★ 705.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.12 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $852,272,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.34 | $0.54 |
| 52 Week High | $24.20 | $4.00 |
| Indicator | TISI | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 53.40 | 48.08 |
| Support Level | $13.48 | $1.33 |
| Resistance Level | $15.00 | $1.81 |
| Average True Range (ATR) | 0.47 | 0.12 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 59.05 | 31.59 |
Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.